Overview of HIV Prevention

  • Author: Sharon L. Hillier, PhD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 8/24/18 (What's New)

Summary

  • Antiretroviral PrEP for HIV infection can be delivered orally or topically as a gel, film, suppository, or sustained-release intravaginal ring[Baeten 2008]
  • WHO recommends offering oral tenofovir DF–containing PrEP to individuals at substantial risk of acquiring HIV as an additional prevention option in combination with other preventive strategies (Management Guidelines)[WHO 2016]
  • CDC provides guidelines on the use of PrEP in MSM (Table 3), in heterosexually active adults (Table 4), and in injecting drug users (Table 5) (Management Guidelines)[CDC PrEP]
    • Oral Pre-Exposure Prophylaxis
      Topical Pre-Exposure Prophylaxis
        Other New Strategies for Pre-Exposure Prophylaxis

        Action required

        Keywords: Biomedical Prevention

        ©2018 Clinical Care Options, LLC. All Rights Reserved.

        The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.